Loading...
Please wait, while we are loading the content...
Similar Documents
To assess the awareness about HPV infection , cervical cancer , HPV vaccine and willingness to pay for HPV vaccine-A cross sectional tertiary hospital based study
| Content Provider | Semantic Scholar |
|---|---|
| Author | Patel, Pankaj M. |
| Copyright Year | 2019 |
| Abstract | Background: High burden of cervical cancer rates and lack of research on human papillomavirus (HPV) vaccine demand in India, the research team assessed the awareness about HPV infection, cervical cancer, HPV vaccine and willingness to pay for HPV vaccine among mother for their daughter. The success of HPV vaccination depends on level of awareness and willingness to pay (WTP) for HPV vaccine in general population. Aim: The primary objective of the study is to assess the demand and WTP amount for bivalent HPV vaccine among women having at least one daughter and visiting for vaccination of their child at vaccination clinic provided under Universal Immunization Program. Methodology: A cross sectional tertiary hospital based study was conducted among women visiting for vaccination of their child for childhood vaccination. An interviewer administered questionnaire covering socio-demographics profile, awareness about HPV infection, cervical cancer, HPV vaccine and WTP for HPV vaccine for their adolescent girls was assessed. WTP was identified by contingent valuation using payment card method. The sample size calculated was 320 with five percent margin of error and 95 percent confidence interval. The socio-demographic profile of the respondents is reported using descriptive statistics. To assess associations between socio-demographic variables and WTP for HPV vaccine, each variable was put individually into a logistic regression analysis. Determinants of WTP were assessed using a multiple linear regression. Results: Total 253 respondents (79 percent) stated positive WTP amount. The average WTP amount stated by the respondents was around US$9.14 (629 INR) for two doses of bivalent HPV vaccine. Fifty percent participants stated their WTP amount US$5.08 (350 INR) or below for two doses of bivalent HPV vaccine. The majority of the respondents (89 percent) have not heard about HPV. Only around forty-two percent of the total respondents have heard about cervical cancer. Conclusion: Creating awareness among the community on cervical cancer, HPV infection and providerinitiated immunization program should be encouraged as these could increase HPV vaccine acceptance. In government funded national immunization program, co-payment could be a feasible approach to ensure sustainable vaccination program. However, vaccination free of cost may be considered for the low-socio economic section of the society in order to ensure equitable vaccination program. Received: July 14, 2019; Accepted: July 24, 2019; Published: August 8, 2019 *Corresponding authors: Dr Pankaj Patel, Indian Institute of Public Health, Delhi; E-mail: drpankajvr@gmail.com |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://symbiosisonlinepublishing.com/vaccine-research/vaccine-research32.pdf |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
